Pathogenic and protective roles of CD45RBlow CD4+ cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse

Diabetes

Volumn 45, Issue 1, 1996, Pages 71-78

  Shimada, Akira ^a   Rohane, Patricia ^a   Fathman, C Garrison ^a,b   Charlton, Brett ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DIABETES MELLITUS; ENTERITIS; ETIOLOGY; FEMALE; INTERFERON PRODUCTION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD45; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; IMMUNOTHERAPY, ADOPTIVE; INFLAMMATORY BOWEL DISEASES; INTESTINE, LARGE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, SCID; SEVERE COMBINED IMMUNODEFICIENCY; SPLEEN;

EID: 0030068383     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.1.71     Document Type: Article

References (35)

1. Shizuru JA, Taylor-Edwards C, Banks BA, Gregory AK, Fathman CG: Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes Science 240:659-662, 1988
2. Hayward AR, Shreiber M: Neonatal injection of CD3 antibody into nonobese diabetic mice reduces the incidence of insulitis and diabetes. J Immunol 143:1555-1559, 1989
3. Bendelac A, Boitard C, Bedossa P, Bazin H, Bach JF, Carnaud C: Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes. J Immunol 141:2625-2628, 1988
4. Lehuen A, Bendelac A, Bach JF, Carnaud C: The nonobese diabetic mouse model: independent expression of humoral and cell-mediated autoimmune features. J Immunol 144:2147-2151, 1990
5. Harada M, Makino S: Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1,2 antibody. Jikken Dobutsu 35:501-504, 1986
6. Makino S, Harada M, Kishimoto Y, Hayashi Y: Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background. Jikken Dobutsu 35.495-498, 1986
7. Ilim SH, Yoon JW: Studies on autoimmunity for initiation of beta-cell destruction. VI. Macrophages essential for development of beta-cell-specific cytotoxic effectors and insulitis in NOD mice. Diabetes 39:1273-1278, 1990
8. Charlton B, Bacelj A, Mandel TE: Administration of silica particles or anti-Lyt2 antibody prevents beta-cell destruction in NOD mice given cyclophosphamide Diabetes 37:930-935, 1988
9. Lee KU, Amano K, Yoon JW: Evidence for initial involvement of macrophage in development of insulitis in NOD mice. Diabetes 37:989-991, 1988
10. Takei I, Asaba Y, Kasatani T, Maruyama T, Watanabe K, Yanagawa T, Saruta T, Ishii T: Suppression of development of diabetes in NOD mice by lactate dehydrogenase virus infection. J Autoimmun 5:665-673, 1992
11. Kasuga A, Maruyama T, Takei I, Shimada A, Kasatani T, Watanabe K, Saruta T, Nakaki T, Habu S, Miyazaki J: The role of cytotoxic macrophages in non-obese diabetic mice: cytotoxicity against murine mastocytoma and beta-cell lines Diabetologia 36:1252-1257, 1993
12. Mutchings P, Rosen H, O'Reilly L, Simpson E, Gordon S, Cooke A: Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature 348:639-642, 1990
13. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y: Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29:1-13, 1980
14. Charlton B, Bacelj A, Slattery RM, Mandel TE: Cyclophosphamide-induced diabetes in NOD/WEHI mice: evidence for suppression in spontaneous autoimmune diabetes inellitus. Diabetes 38:441-447, 1989
15. Yasunami R, Bach JF: Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunol 18:481-484, 1988
16. Rohane PW, Shimada A, Kim DT, Edwards CT, Charlton B, Shultz LD, Fathman CG: Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice. Diabetes 44:550-554, 1995
17. Boitard C, Yasunami R, Dardenne M, Bach JF: T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 169:1669-1680, 1989
18. Mutchings PR, Cooke A. The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. J Autoimmun 3:175-185, 1990
19. Chosich N, Harrison LC: Suppression of diabetes mellitus in the nonobese diabetic (NOD) mouse by an autoreactivc (anti-I-Ag7) islet-derived CD4+ T-cell line, Diabetologia 36:716-721, 1993
20. Powrie F, Mason D: OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset. J Exp Med 172.1701-1708, 1990
21. Fowell D, Mason D: Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential. J. Exp Med 177:627-636, 1993
22. Morrissey PJ, Charrier K, Braddy S, Liggitt D, Watson JD: CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice: disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med 178:237-244, 1993
23. Powrie F, Correa-Oliveira R, Mauze S, Coffman RL: Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 179:589-600, 1994
24. Prochazka M, Gaskins HR, Shultz LD, Leiter EH: The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci USA 89:3290-3294, 1992
25. Custer RP, Bosma GC, Bosma MJ: Severe combined immunodeficiency (SCID) in the mouse: pathology, reconstitution, neoplasms. Am J Pathol 120:464-477, 1985
26. Christianson SW, Shultz LD, Leiter EH: Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice: relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-la donors. Diabetes 42:44-55, 1993
27. Miltcnyi S, Muller W, Weichel W, Radbruch A: High gradient magnetic cell separation with MACS. Cytometry 11:231-238, 1990
28. Sempe P, Richard M-F, Bach J-F, Boitard C: Evidence of CD4+ regulatory T cells in the non-obese diabetic male mouse. Diabetologia 37:337-343, 1994
29. Koike T. Itoll Y, Ishii T, Ito I, Takabayashi K, Maruyaiua N, Tomioka H, Yoshida S: Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes 36:539-541, 1987
30. Wang Y, Hao L, Gill RG, Lafferty KJ: Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent Diabetes 36:535-538, 1987
31. Miller BJ, Appel MC, O'Neil JJ, Wicker LS: Both the Lyt-2+ and C3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol 140.52-58, 1988
32. Yagi H, Matsumoto M, Kunimoto K, Kawaguchi J, Makino S, Harada M: Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. Eur J Immunol 22:2387-2393, 1992
33. Powrie F, Leach MW, Mauze S, Menon S, Caddle LB. Coffman RL: Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1:553-562, 1994
34. Bottomly K, Luqman M, Greenbaum L, Carding S, West J, Pasqualini T, Murphy DB: A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines. Eur J Immunol 19:617-623, 1989
35. Scott B, Liblau R, Degermann S, Marconi LA, Ogata L, Caton AJ, McDevitt HO, Lo D: A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity Immunity 1:73-79, 1994